Financials

  • Market Capitalization 209.28 M
  • Employee 122
  • Founded 2020
  • CEO N/A
  • Website www.invivyd.com
  • Headquarter Delaware, United States
  • FIGI BBG00W4ML039
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-8.23
Rapporto prezzo/fatturato
7.96

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
3508
LYEL
Lyell Immunopharma, Inc. - Common Stock
8.62 USD-1.03%-4.86%-27.99%-64.37%211.23 M USD
3509
NAGE
Niagen Bioscience, Inc. - Common Stock
2.62 USD-2.60%-3.68%-13.82%-47.39%207.31 M USD
3540
ELDN
Eledon Pharmaceuticals, Inc. - Common Stock
2.47 USD-0.40%-1.98%-11.15%-11.79%200.72 M USD
3541
CGEN
Compugen Ltd. - Ordinary Shares
2.12 USD-0.47%-7.02%-12.40%+7.61%200.45 M USD

Notizie